Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A ‘Novel’ Investment In Psychedelic-Inspired Medicines

Stockhouse investors are keenly aware of the booming trend in the psychedelic healthcare space…in many ways the new Cannabis 2.0 over the last 12 – 24 months. Capital markets have taken to them en masse – a market now estimated to be in excess of USD$5 billion and expected ...
Dave Jackson | April 16, 2021 |

Real Estate Crash The Next Shoe To Drop – Part III

Our continued research into the state and status of the Real Estate market continues to point to a process that is starting to unfold in the US which may put price and activity levels at risk. Within the past two segments of this research article, we’ve highl...
Chris Vermeulen | April 23, 2020 |

Clinical Catalysts Impending for California-Based Biopharma

The firm's three upcoming potential stock movers are reviewed in a ROTH Capital Partners report. In a March 17 research note, ROTH Capital Partners analyst Zegbeh Jallah presented the events that could positively impact Turning Point Therapeutics Inc.'s (TP...
Streetwise Reports | March 19, 2020 |

Aben Resources: Mines are built not found

Exploration is a hunt for minerals. If it was as easy as flying a helicopter survey, taking a few soil samples, and then punching in some corresponding holes, everyone would be successful at it. But it doesn’t work that way, the earth guards her secrets close...
Richard (Rick) Mills | September 25, 2019 |

Goodbye Goldcorp, Hello Newmont

Goodbye Goldcorp, Hello Newmont Source: Adrian Day for Streetwise Reports 04/22/2019 Fund manager Adrian Day reviews the Goldcorp-Newmont merger as well as provides updates on a number of resource companies in his portfolio, including some that he sees as good buys....
Streetwise Reports | April 23, 2019 |